|
|
| October 15, 2008: Dr. Cohen and Dr. Gibson Provide an Update on the Economics of Drug Eluting Stents: Insights from the Medicare Database |
Dr. David Cohen and Dr. C. Michael Gibson Provide an Update on the Economics of Drug
Eluting Stents- Insights from the Medicare Database at TCT 2008.
Disclosures for Dr. Gibson at the time of filming:
Present Research/Grant Funding
Schering Plough Corporation; Sanofi-Aventis; Baxter; FoldRx; Genentech, Inc.; Astra
Zeneca; HeartScape Technologies; Fold Rx; Abbott; Cardica, Inc.; Johnson & Johnson
Corporation; FibroGen, Inc.
Speakers Bureau
Schering Plough Corporation; Eli Lilly and Company; Daiichi Sankyo Company, Inc;
Consultant
The Medicines Company; Bayer Corporation; Archemix Corporation; Heartscape Technologies,
Inc.; Angel Medical Systems; Schering Plough Corporation; Portola Corporation; John &
Johnson Corporation; ICON Medical Imaging; Jim Moran Heart and Vascular Research Institute
Stock Ownership
My wife owns stock in HealthMarx Inc.
Royalties as a Contributor
UpToDate in Cardiovascular Medicine
Past Research/Grant Funding/Past Speakers Bureau/Past Consulting
ActivBiotics, Inc.; Acusphere, Inc.; Astra; Sanofi-Aventis Corporation; Bard Corporation;
Boston Scientific Corporation; Bristol Meyers Squibb Company; British Biotech, plc.; Ciba
Geigy Corporation; Corgentech, Inc.; COR Therapeutics; DVI Guidant Corporation;
GlaxoSmithKline; Genentech, Inc.; Merck & Co., Inc.; Millennium Pharmaceuticals; NIH;
Pfizer; Percusurge, Inc.; Smith Kline Beecham; Sonus; St. Jude Medical; timi3 Systems,
Inc.; Ascenta Therapeutics, Inc; CardioKinetix, Inc.; Eli Lilly and Company; KAI
Pharmaceuticals; Nuvelo; INO Therapeutics, LLC; Point Biomedical Corporation; Portola
Pharmaceuticals, Inc.; The Medicines Company; Ascenta Therapeutics; Atrium Medical
Corporation; Biogen IDEC; PDL Pharmaceuticals; timi3 Systems; Momenta Pharmaceuticals;
Novartis Corporation;
Current disclosures for Dr. Gibson can be found at:
http://en.wikidoc.org/index.php/C._Michael_Gibson
[ Download video ] |
|
No comments have been submitted
|